UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of risk factors for involuntary psychiatric hospitalization: using environmental socioeconomic data and methods of machine learning to improve prediction

BMC psychiatry, 2020-08, Vol.20 (1), p.401-14, Article 401

2020

Volltextzugriff (PDF)

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

Addiction (Abingdon, England), 2006-03, Vol.101 (3), p.348-361

2006

Volltextzugriff (PDF)

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

Journal of neurology, neurosurgery and psychiatry, 2000-06, Vol.68 (6), p.719-725

2000

Volltextzugriff (PDF)

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

Pharmacopsychiatry, 2005-11, Vol.38 (6), p.301-311

2005

Volltextzugriff (PDF)

Behandlungsvereinbarungen in der Psychiatrie – reale Praxis in einem Verbund psychiatrischer Kliniken

Nervenarzt, 2023, Vol.94 (1), p.18-26

2023

Volltextzugriff (PDF)

Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project

European archives of psychiatry and clinical neuroscience, 2021-09, Vol.271 (6), p.1005-1016

2021

Volltextzugriff (PDF)

Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines

European archives of psychiatry and clinical neuroscience, 2018-04, Vol.268 (3), p.219-229

2018

Volltextzugriff (PDF)

Joint crisis plans in mental health hospitals-Real practice in an association of psychiatric hospitals

Nervenarzt, 2023-01, Vol.94 (1), p.18-26

2023

Volltextzugriff (PDF)

Cortical thinning in amphetamine-type stimulant users

Neuroscience, 2012-09, Vol.221, p.182-192

2012

Volltextzugriff (PDF)

Schizophrenia and Comorbid Substance Use Disorder: Integrated Psychosocial Treatment in a Community Psychiatric Hospital: Results From an Rct with 12 Months Follow-up

European psychiatry, 2015-03, Vol.30, p.392

2015

Volltextzugriff (PDF)

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Journal of psychopharmacology (Oxford), 2010-10, Vol.24 (10), p.1515-1524

2010

Volltextzugriff (PDF)

Doble diagnosis--psychosis and addiction

Fortschritte der Neurologie, Psychiatrie, 2006-09, Vol.74 (9), p.528

Gouzoulis-Mayfrank, E

2006

Volltextzugriff (PDF)

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users

Journal of Neural Transmission, 2007-08, Vol.114 (8), p.959-968

2007

Volltextzugriff (PDF)

Konzept eines modularen, sektorübergreifenden Versorgungs- und Vergütungsmodells für die bedarfsorientierte Behandlung psychischer Erkrankungen als Alternative zu PEPP

Psychiatrie (Stuttgart, Germany), 2015-04, Vol.12 (2), p.118-127

2015

Volltextzugriff (PDF)

Mental comorbidities of alcohol-related disorders

Nervenarzt, 2016-01, Vol.87 (1), p.26-34

2016

Volltextzugriff (PDF)

Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis--a longitudinal study

European archives of psychiatry and clinical neuroscience, 2004-12, Vol.254 (6), p.415-421

2004

Volltextzugriff (PDF)

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

Psychopharmacology, 2004-05, Vol.173 (3-4), p.398-404

2004

Volltextzugriff (PDF)

Comorbidity of substance use and other psychiatric disorders--theoretical foundation and evidence based therapy

Fortschritte der Neurologie, Psychiatrie, 2008-05, Vol.76 (5), p.263

Gouzoulis-Mayfrank, E

2008

Volltextzugriff (PDF)

A case of Bleuler's disease? 100 years of dementia praecox or group of schizophrenias

Nervenarzt, 2013-03, Vol.84 (3), p.381

2013

Volltextzugriff (PDF)

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans

Behavioural pharmacology, 1998-11, Vol.9 (7), p.561-566

1998

Volltextzugriff (PDF)

Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city

Nervenarzt, 2010-03, Vol.81 (3), p.323

2010

Volltextzugriff (PDF)

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

Journal of psychopharmacology (Oxford), 2007-05, Vol.21 (3), p.312-320

2007

Volltextzugriff (PDF)

State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial

Nervenarzt, 2012-07, Vol.83 (7), p.888

2012

Volltextzugriff (PDF)

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

Journal of Psychopharmacology, 2006-03, Vol.20 (2), p.188-193

2006

Volltextzugriff (PDF)

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers: Results of an experimental double-blind placebo-controlled study

Psychopharmacologia, 1999-02, Vol.142 (1), p.41-50

1999

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(72)
Deutsch
(53)

Erscheinungsjahr

n.n

Thema

Humans
(63)
Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Psychiatry
(54)
Neurosciences & Neurology
(43)
Adult
(39)
Male
(38)
Female
(36)
Biological And Medical Sciences
(26)
Clinical Neurology
(26)
Neurosciences
(26)
Ecstasy
(21)
Medical Sciences
(21)
Pharmacology & Pharmacy
(20)
N-Methyl-3,4-Methylenedioxyamphetamine - Adverse Effects
(16)
Schizophrenia
(15)
Neurotoxicity
(14)
Psychology. Psychoanalysis. Psychiatry
(14)
Mdma
(13)
Middle Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of risk factors for involuntary psychiatric hospitalization: using environmental socioeconomic data and methods of machine learning to improve prediction

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

Behandlungsvereinbarungen in der Psychiatrie – reale Praxis in einem Verbund psychiatrischer Kliniken

Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project

Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines

Joint crisis plans in mental health hospitals-Real practice in an association of psychiatric hospitals

Cortical thinning in amphetamine-type stimulant users

Schizophrenia and Comorbid Substance Use Disorder: Integrated Psychosocial Treatment in a Community Psychiatric Hospital: Results From an Rct with 12 Months Follow-up

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Doble diagnosis--psychosis and addiction

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users

Konzept eines modularen, sektorübergreifenden Versorgungs- und Vergütungsmodells für die bedarfsorientierte Behandlung psychischer Erkrankungen als Alternative zu PEPP

Mental comorbidities of alcohol-related disorders

Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis--a longitudinal study

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

Comorbidity of substance use and other psychiatric disorders--theoretical foundation and evidence based therapy

A case of Bleuler's disease? 100 years of dementia praecox or group of schizophrenias

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans

Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers: Results of an experimental double-blind placebo-controlled study

Suchergebnisse filtern